This is the fifth installment in the series on changes coming to the clinical research enterprise from John Neal, CPA, BS, CRSP, founder and CEO of PCRS Network, LLC, and member of the ACRP Board of Trustees
Prediction 5: Attention will turn more toward prevention, rather than cures. To be fair, rarely is there […]
This is the fourth installment in a series on changes coming to the clinical research enterprise from John Neal, CPA, BS, CRSP, founder and CEO of PCRS Network, LLC, and member of the ACRP Board of Trustees.
Prediction 4: Fewer Principal Investigators will be needed in the future. Following my first three posts […]
Imagine you are a research nurse/clinical research coordinator (CRC) for an in-patient randomized, double-blind study that aims to lower “bad” cholesterol. One of your subjects is seen by a resident who is not on the study team, and who orders a lipid panel, the positive results of which are then shared with your subject by […]
When it comes to reporting ongoing data updates in clinical trials, less is sometimes more, according to Lynn Meyer, CCRP, president of IntegReview IRB in Austin, Texas. “There’s a lot of wasted energy spent on over-reporting ongoing trial results,” she says. Unnecessary reporting to institutional review boards (IRBs) can cost an extra $5,000 per site, […]
Dan Dumrauf, director at Medix Scientific, understands the unique challenges of identifying leading resource talent for the clinical research industry, and is not afraid to confront obstacles head on.
